A 6 Week Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD ( Attention Deficit/Hyperactivity )
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Neurocognitive Unit Rambam Mc
Haifa, Israel
- Adhd Unit Geha Mc
Petah Tikva, Israel
- Sarkis Clinical Trials
Gainesville, Florida, United States
- Miami Research
South Miami, Florida, United States
- Capstone Clinical Research
Libertyville, Illinois, United States
- Psychiatric Associates
Overland Park, Kansas, United States
- University Kentucky Psychiatry
Lexington, Kentucky, United States
- Pediatric Psychopharmacology & Adult Adhd Program, Massachusetts General Hospital
Boston, Massachusetts, United States
- Rochester Center for Behavioral Medicine
Rochester Hills, Michigan, United States
- Behavioral Medicine Center
Troy, Michigan, United States
- St. Charles Psychiatric Associates
Saint Charles, Missouri, United States
- Center for Psychiatry and Behavioral Medicine
Las Vegas, Nevada, United States
- Bioscience Research
Mount Kisco, New York, United States
- Duke University
Durham, North Carolina, United States
- Richard H Weisler, Md, Pa
Raleigh, North Carolina, United States
- Sequoia Behavioral Healthcare
Media, Pennsylvania, United States
- Futureresearch Trials
Austin, Texas, United States
- Futureresearch Trials Dallas, Lp
Dallas, Texas, United States
- Bayou City Research
Houston, Texas, United States
- Neuroscience, Inc. (nsi)
Herndon, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2014
- Primary completion
- 30 Sept 2014
- Completion
- 30 Sept 2014
- Last update posted
- 28 Mar 2017
- Registered enrollment
- 300
- Registry id
- NCT02059642
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.